US patent allowance boosts Solvonis' SVN-SDN-14 PTSD programme value

By Proactive Investors / January 13, 2026 / www.youtube.com / Article Link

Solvonis Therapeutics PLC CEO Anthony Tennyson discusses key developments across the company's pipeline, including ...

Recent News

Metals far outpacing tech over past year

February 09, 2026 / www.canadianminingreport.com

Gold stocks gain on metal recovery

February 09, 2026 / www.canadianminingreport.com

Immediate trigger for crash was new Fed Chairman pick

February 02, 2026 / www.canadianminingreport.com

Gold stocks slump on metal price decline

February 02, 2026 / www.canadianminingreport.com

Is the gold market starting to turn 'irrationally exuberant'?

January 26, 2026 / www.canadianminingreport.com

See all >